BCL2L1 and Miyoshi myopathy: In addition, clonal plasma cells in this subgroup of MM patients exhibit a higher level of expression of the antiapoptotic protein BCL-2, and a lower level of expression of proapoptotic protein MCL-1/BCL-XL, making them susceptible to BCL-2 inhibition [17].